| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.neogenchem.com | |
| Market Cap | 3,007.56 Cr. | |
| Enterprise Value(EV) | 3,287.30 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 18.87 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 64.00 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 25.92 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 181.76 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 6.65 | Calculated using Price: 1,208.00 |
| Dividend Yield | 0.23 | Period Ending 2022-03 |
| No. of Shares Subscribed | 2.49 Cr. | 24,939,316 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Neogen Chemicals is one of India's leading manufacturers of bromine-based, and lithium-based, specialty chemicals. The company manufactures specialty organic bromine-based chemical compounds (Bromine Compounds) and other specialty organic chemical compounds as well as specialty inorganic lithium-based chemicals compounds (Lithium Compounds and together with the Bromine Compounds the Products). In addition to manufacturing its standard products, the company also undertakes custom synthesis and contract manufacturing. In custom synthesis the product is developed and customized primarily for a specific customer, but process know-how and technical specifications are developed in-house by it. | ||
| 1 Day |
|
-1.04% |
| 1 Week |
|
-1.23% |
| 1 Month |
|
-2.98% |
| 3 Month |
|
-18.97% |
| 6 Month |
|
-11.62% |
| 1 Year |
|
-28.81% |
| 2 Year |
|
+70.32% |
| 5 Year |
|
|
| 10 Year |
|
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 18.59 | 23.61 | 20.30 | 22.00 | 23.70 | 34.56 | 25.21 | 18.47 | 14.34 | |
| Return on Capital Employed (%) | 24.32 | 27.42 | 26.11 | 23.01 | 22.82 | 25.46 | 21.88 | 16.75 | 14.33 | |
| Return on Assets (%) | 5.79 | 7.72 | 6.94 | 6.57 | 6.58 | 9.77 | 9.49 | 7.40 | 6.91 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 20 | 23 | 28 | 42 | 50 | 70 | 156 | 183 | 439 | 453 | |
| Non Curr. Liab. | 7 | 7 | 7 | 44 | 46 | 60 | 49 | 131 | 142 | 141 | |
| Curr. Liab. | 37 | 38 | 46 | 67 | 84 | 117 | 150 | 178 | 218 | 308 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 63 | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 903 | |
| Non Curr. Assets | 17 | 16 | 20 | 63 | 74 | 87 | 124 | 252 | 307 | 326 | |
| Curr. Assets | 46 | 53 | 61 | 90 | 107 | 160 | 231 | 240 | 492 | 577 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 63 | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 903 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 74 | 84 | 100 | 110 | 161 | 239 | 306 | 336 | 487 | 585 | |
| Other Income | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | |
| Total Income | 74 | 85 | 100 | 110 | 162 | 240 | 306 | 337 | 488 | 588 | |
| Total Expenditure | -62 | -71 | -86 | -90 | -132 | -196 | -248 | -272 | -401 | -486 | |
| PBIDT | 12 | 14 | 14 | 20 | 30 | 44 | 58 | 65 | 88 | 102 | |
| Interest | -5 | -5 | -5 | -8 | -10 | -12 | -12 | -14 | -19 | -24 | |
| Depreciation | -1 | -1 | -1 | -1 | -2 | -3 | -5 | -7 | -12 | -15 | |
| Taxation | -3 | -3 | -3 | -4 | -6 | -8 | -12 | -13 | -12 | -15 | |
| Exceptional Items | |||||||||||
| PAT | 4 | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 47 | |
| Minority Interest | |||||||||||
| Share Associate | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 4 | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 47 | |
| Adjusted EPS | 8 | 11 | 3 | 4 | 5 | 10 | 12 | 13 | 18 | 19 |
| Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 3 | 9 | 9 | 0 | 12 | -4 | -35 | 84 | 1 | |
| Cash Fr. Inv. | -1 | -2 | -4 | -33 | -13 | -20 | -29 | -135 | -146 | |
| Cash Fr. Finan. | -2 | -6 | -4 | 33 | 0 | 24 | 63 | 51 | 188 | |
| Net Change | 0 | 1 | 0 | 1 | -1 | 0 | -1 | 0 | 44 | |
| Cash & Cash Eqvt | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 45 |
|
Sat, 31 Dec 2022
Closure of Trading Window This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and the Companys Code for Prevention of Insider Trading (Insider Trading Policy) the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons connected persons and legitimate insiders of the Company from Sunday January 1 2023 till the end of 48 hours after the declaration of unaudited financial results of the Company for the quarter ended December 31 2022. |
|
Tue, 20 Dec 2022
Announcement under Regulation 30 (LODR)-Credit Rating Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Regulation) we would like to submit the ratings received from ICRA Limited. |
|
Sat, 12 Nov 2022
Announcement under Regulation 30 (LODR)-Earnings Call Transcript With reference to the captioned subject please find enclosed herewith the Earnings Call Transcript of the Companys Q2 & H1 FY23 Earnings Conference Call held on Monday November 7 2022. The transcript is also being uploaded on the companys website at https://neogenchem.com/financialperformance/.Kindly take the same on your record. |
| Fri, 27 Jan 2023 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Close Crossing Last Week Low
|
Opening at High
|
Equities
M.F.
Sectors